27 results found
Jay Bhattacharya, the controversial NIH Director, has been appointed acting CDC Director, marking an unusual dual role amidst Health Secretary Robert F. Kennedy Jr.'s leadership shake-up. Critics express alarm over Bhattacharya's perceived lack of leadership and history of endorsing anti-vaccine policies, fearing further destabilization of public health agencies and a rubber-stamping of unscientific agendas.
After nearly 15 years, Remitly co-founder and CEO Matt Oppenheimer is transitioning to board chair, handing the reins to Sebastian Gunningham. Oppenheimer reflects on the fintech giant's journey from a three-person startup to a $3B public company, sharing invaluable lessons on customer focus, cultural development, and leadership growth.
